Literature DB >> 23972704

Biology and treatment of advanced renal cell carcinoma: a global perspective.

Brian I Rini1, Tom Powles.   

Abstract

Entities:  

Mesh：

Year:  2013        PMID： 23972704     DOI： 10.1053/j.seminoncol.2013.05.003

Source DB:  PubMed          Journal:  Semin Oncol        ISSN： 0093-7754            Impact factor:   4.929


× No keyword cloud information.
  2 in total

1.  Harnessing the p53-PUMA axis to overcome DNA damage resistance in renal cell carcinoma.

Authors:  Xiaoguang Zhou; Yanis Tolstov; Aysenur Arslan; Wilfried Roth; Carsten Grüllich; Sascha Pahernik; Markus Hohenfellner; Stefan Duensing
Journal:  Neoplasia       Date:  2014-12       Impact factor: 5.715

2.  A serum metabolomic fingerprint of bevacizumab and temsirolimus combination as first-line treatment of metastatic renal cell carcinoma.

Authors:  Elodie Jobard; Ellen Blanc; Sylvie Négrier; Bernard Escudier; Gwenaelle Gravis; Christine Chevreau; Bénédicte Elena-Herrmann; Olivier Trédan
Journal:  Br J Cancer       Date:  2015-09-15       Impact factor: 7.640
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.